0
Skip to Content
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
NMD Pharma
Home
About
About NMD Pharma
Management team
Our team
Board
Founders
R&D
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
News
Press releases
Events
Other news
Investors
Careers
Your career
Find your job
Contact
Home
Folder: About
Back
About NMD Pharma
Management team
Our team
Board
Founders
Folder: R&D
Back
Pipeline
Science
Neuromuscular diseases
Insights
Scientific publications
Folder: News
Back
Press releases
Events
Other news
Investors
Folder: Careers
Back
Your career
Find your job
Contact
Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis</a>
Stine Krag Brunvold 3/11/19 Stine Krag Brunvold 3/11/19

Interview with Professor, Dr. Geert Jan Groeneveld about myasthenia gravis

It all begins with an idea.

Read More
NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670</a>
Stine Krag Brunvold 3/11/19 Stine Krag Brunvold 3/11/19

NMD Pharma Doses the First Myasthenia Gravis Patient in a Combined Phase I/IIa Clinical Trial of NMD670

It all begins with an idea.

Read More
Blog Post Title Three
Stine Krag Brunvold 3/11/19 Stine Krag Brunvold 3/11/19

Blog Post Title Three

It all begins with an idea.

Read More
Blog Post Title Four
Stine Krag Brunvold 3/11/19 Stine Krag Brunvold 3/11/19

Blog Post Title Four

It all begins with an idea.

Read More

NMD PHARMA A/S, CVR No. 36899069

Cookie Policy Terms of Use Privacy Policy US Expanded Access Policy

Follow us
LinkedIn and X